The success of cellular therapies in patients with SUI

SAP Partner | <b>Vanderbilt University Medical Center</b>

In this video, Melissa R. Kaufman, MD, PhD, FACS, discusses the takeaways from the study, “A double-blind, randomized, controlled trial comparing safety and efficacy of autologous muscle derived cells for urinary sphincter repair (AMDC-USR) with placebo (PBO) in women with stress urinary incontinence (SUI),” presented during the 2021 American Urological Association annual meeting. Kaufman is a professor of urology and chief of the division of reconstructive urology and pelvic health at Vanderbilt University, Nashville, Tennessee.